首页|痰热清注射液联合泼尼松龙治疗乳腺癌合并急性放射性肺炎的疗效

痰热清注射液联合泼尼松龙治疗乳腺癌合并急性放射性肺炎的疗效

扫码查看
目的 探讨痰热清注射液联合泼尼松龙治疗乳腺癌合并急性放射性肺炎的疗效.方法 采用随机数字表法将68例乳腺癌合并急性放射性肺炎患者分为对照组和联合组,每组34例.对照组采取泼尼松龙治疗,联合组在对照组的基础上加用痰热清注射液治疗.比较两组患者的疗效、放射性肺炎分级情况[美国肿瘤放射治疗协作组(RTOG)分级标准]、生活质量[卡氏功能状态(KPS)评分、乳腺癌患者生命质量测定量表(FACT-B)]、肺纤维化指标[层粘连蛋白(LN)、Ⅰ型前胶原羧基端肽(PⅠCP)、Ⅲ型前胶原(PCⅢ)]及不良反应发生情况.结果 联合组患者总缓解率高于对照组,差异有统计学意义(P<0.05).治疗后,联合组患者放射性肺炎分级情况优于对照组,差异有统计学意义(P<0.05).治疗后,两组患者KPS、FACT-B评分均升高,且联合组患者KPS、FACT-B评分均高于对照组,差异均有统计学意义(P<0.05).治疗后,两组患者LN、PⅠCP、PCⅢ水平均降低,且联合组患者LN、PⅠCP、PCⅢ水平均低于对照组,差异均有统计学意义(P<0.05).两组患者不良反应总发生率比较,差异无统计学意义(P>0.05).结论 对乳腺癌合并急性放射性肺炎患者采取痰热清注射液联合泼尼松龙治疗可取得较好的效果,可显著缓解患者病情,降低放射性肺炎分级,提高生活质量,减轻肺纤维化,且用药安全.
Curative effect of Tanreqing injection combined with prednisolone on breast cancer complicated with acute radiation pneumonia
Objective To investigate the curative effect of Tanreqing injection combined with prednisolone on breast cancer complicated with acute radiation pneumonia.Method A total of 68 patients of breast cancer complicated with acute radiation pneumonia were divided into control group and combined group with 34 cases in each group by random number table method.The control group was treated with prednisolone and the combined group was treated with Tanreq-ing injection on the basis of the control group.The therapeutic effect,radiation pneumonia grade[Radiation Therapy On-cology Group(RTOG)grading standard],quality of life[Kamofsky performance status(KPS)score,functional assess-ment of cancer therapy-breast(FACT-B)],pulmonary fibrosis index[laminin(LN),procollagen type Ⅰ carboxy-terminal propeptide(PICP),procollagen type Ⅲ(PCⅢ)]and the occurrence of adverse reactions were compared between the two groups.Result The total response rate of combined group was higher than that of control group,the difference was sta-tistically significant(P<0.05).After treatment,the grade of radiation pneumonia in combined group was better than that in control group,and the difference was statistically significant(P<0.05).After treatment,the KPS and FACT-B scores were increased in both groups,and the KPS and FACT-B scores in combined group were higher than those in control group,the differences were statistically significant(P<0.05).After treatment,the levels of LN,PICP and PCⅢ in two groups were decreased,and the levels of LN,PICP and PCⅢ in combined group were lower than those in control group,the differences were statistically significant(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Tanreqing injection combined with prednisolone can achieve a good effect in the treatment of breast cancer patients with acute radiation pneumonia,which can significantly alleviate the condition of patients,reduce the grade of radiation pneumonia,improve the quality of life,alleviate pulmonary fibrosis,and the drugs are safe.

Tanreqing injectionprednisolonebreast canceracute radiation pneumoniaquality of lifepulmonary fibrosiscurative effect

杨功强、方中平、王金梅

展开 >

信阳市中心医院急诊内科,河南 信阳 464000

痰热清注射液 泼尼松龙 乳腺癌 急性放射性肺炎 生活质量 肺纤维化 疗效

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(2)